These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
35 results:

  • 1. Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system.
    Spisak S; Chen D; Likasitwatanakul P; Doan P; Li Z; Bala P; Vizkeleti L; Tisza V; De Silva P; Giannakis M; Wolpin B; Qi J; Sethi NS
    Nat Commun; 2024 Mar; 15(1):2230. PubMed ID: 38472198
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. POLE-Mutant Colon Adenocarcinoma-Case Presentation and Histopathological Evaluation.
    Pancsa T; Vasas B; Melegh Z; Tóth E; Torday L; Sejben A
    J Gastrointest Cancer; 2024 Jun; 55(2):961-964. PubMed ID: 38175383
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hafnium (Hf)-Chelating Porphyrin-Decorated Gold Nanosensitizers for Enhanced Radio-Radiodynamic Therapy of Colon Carcinoma.
    Li J; Lv Z; Guo Y; Fang J; Wang A; Feng Y; Zhang Y; Zhu J; Zhao Z; Cheng X; Shi H
    ACS Nano; 2023 Dec; 17(24):25147-25156. PubMed ID: 38063344
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.
    Tessier-Cloutier B; Kommoss FKF; Kolin DL; Němejcová K; Smith D; Pors J; Stewart CJR; McCluggage WG; Foulkes WD; von Deimling A; Köbel M; Lee CH
    Mod Pathol; 2024 Jan; 37(1):100374. PubMed ID: 37925057
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of Primary Cilia Potentiates
    Remo A; Grillo F; Mastracci L; Simbolo M; Fassan M; Cecchini MP; Miscio G; Sassano A; Parente P; Vanoli A; Sabella G; Giordano G; Urso ED; Cerulo L; Scarpa A; Fiorica F; Pancione M
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239344
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. smarcb1/ini1-Deficient Poorly Differentiated Carcinoma of the Colon With Rhabdoid Features-A Rare Tumor With Serrated Phenotype: Case Report and Review of Literature.
    Maurya S; Yadav S; Bhowmik S; Dhal J; Mehra L; Sharma R; Krishna A; Sharma A; Barwad A; Das P
    Int J Surg Pathol; 2024 Feb; 32(1):187-195. PubMed ID: 37128676
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]    [Full Text] [Related]  

  • 8. Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in colorectal cancer.
    Lyons NJ; Giri R; Begun J; Clark D; Proud D; He Y; Hooper JD; Kryza T
    Antioxid Redox Signal; 2023 Jul; 39(1-3):186-205. PubMed ID: 36792932
    [No Abstract]    [Full Text] [Related]  

  • 9. Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, ini1/smarcb1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas.
    Ahadi MS; Fuchs TL; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
    Histopathology; 2022 May; 80(6):906-921. PubMed ID: 34951482
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review.
    Duan H; Gao W; Wang L; Cao F; Teng L
    Diagn Pathol; 2021 Apr; 16(1):30. PubMed ID: 33836796
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
    Van Treeck BJ; Thangaiah JJ; Torres-Mora J; Stevens TM; Rothermundt C; Fassan M; Loupakis F; Diebold J; Hornick JL; Halling KC; Folpe AL
    Mod Pathol; 2021 Aug; 34(8):1547-1557. PubMed ID: 33714983
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
    Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
    Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
    Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
    Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Loss of switch/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas.
    Tessier-Cloutier B; Schaeffer DF; Bacani J; Marginean CE; Kalloger S; Köbel M; Lee CH
    Histopathology; 2020 Jul; 77(1):46-54. PubMed ID: 32413172
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
    Villatoro TM; Ma C; Pai RK
    Hum Pathol; 2020 May; 99():53-61. PubMed ID: 32222462
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Hereditary predisposition to tumors of the central and peripheral nervous systems].
    Sourty B; Rousseau A
    Ann Pathol; 2020 Apr; 40(2):168-179. PubMed ID: 32192808
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Loss of smarcb1 expression in colon carcinoma.
    Melloul S; Mosnier JF; Masliah-Planchon J; Lepage C; Le Malicot K; Gornet JM; Edeline J; Dansette D; Texereau P; Delattre O; Laurent Puig P; Taieb J; Emile JF
    Cancer Biomark; 2020; 27(3):399-406. PubMed ID: 32083567
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CROCC-mutated rhabdoid colorectal carcinoma showing in intercellular spaces lamellipodia and cellular projections revealed by electron microscopy.
    Remo A; Cecchini MP; Benati D; Bernardi P; Manfrin E; Giordano G; Bonomi F; Parcesepe P; Fassan M; Colombari R; Sbarbati A; Pancione M
    Virchows Arch; 2019 Aug; 475(2):245-249. PubMed ID: 30852641
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comprehensive evaluation of coding region point mutations in microsatellite-unstable colorectal cancer.
    Kondelin J; Salokas K; Saarinen L; Ovaska K; Rauanheimo H; Plaketti RM; Hamberg J; Liu X; Yadav L; Gylfe AE; Cajuso T; Hänninen UA; Palin K; Ristolainen H; Katainen R; Kaasinen E; Tanskanen T; Aavikko M; Taipale M; Taipale J; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Ongen H; Dermitzakis ET; Kilpivaara O; Vahteristo P; Turunen M; Hautaniemi S; Tuupanen S; Karhu A; Välimäki N; Varjosalo M; Pitkänen E; Aaltonen LA
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30108113
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.